Gaoxiang Ai

Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway

Cailan Li, Gaoxiang Ai, Yongfu Wang et al. · Pharmacological Research · 2019 · 246 citations

Microbiota Structure, Microbiota Function, Dysbiosis +14

Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways

Yaoxing Dou, Ronglei Huang, Qiaoping Li et al. · Biomedicine & Pharmacotherapy · 2021 · 82 citations · Full text

Lipid Peroxidation, Redox Biology, Insulin Signaling +17

Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways

Juanjuan Cheng, Xingdong Ma, Gaoxiang Ai et al. · Drug Design Development and Therapy · 2022 · 79 citations · Full text

Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport

Yuxuan Gan, Gaoxiang Ai, Jiazhen Wu et al. · Journal of Ethnopharmacology · 2019 · 51 citations

Inflammation, Anti-inflammatory, Allergy +9

Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways

Lihua Tan, Yongfu Wang, Gaoxiang Ai et al. · International Immunopharmacology · 2019 · 37 citations · Full text